Pfizer Halts Phase III Trial of Cancer Drug in NHL Due to Futility Pharmaceutical Technology Magazine The drug was administered once a month in combination with Roche's Rituxan (rituximab) and compared with either Teva's Treanda (bendamustine) plus rituximab , or Eli Lilly's Gemzar (gemcitabine) plus rituximab. An independent data monitoring committee ... |
